Advertisement

Meyka AI - Contribute to AI-powered stock and crypto research platform
Meyka Stock Market API - Real-time financial data and AI insights for developers
Advertise on Meyka - Reach investors and traders across 10 global markets
Loading...

Carmat SA

CKMTFPNK
Healthcare
Medical - Devices
$12.75
$-13.25(-50.96%)
U.S. Market opens in 14h 46m

Carmat SA Fundamental Analysis

Carmat SA (CKMTF) shows weak financial fundamentals with a PE ratio of -4.96, profit margin of -19.25%, and ROE of 2.58%. The company generates $0.0B in annual revenue with N/A year-over-year growth of N/A.

Key Strengths

PEG Ratio-0.06
Current Ratio2.07

Areas of Concern

ROE2.58%
Operating Margin-18.75%
Cash Position2.54%
We analyze CKMTF's fundamental strength across five key dimensions.

The stock receives a Fundamental Health Score of -1730.1/100 based on profitability, valuation, growth, and balance sheet metrics. The F grade reflects weak fundamentals and significant financial concerns.

Fundamental Health Score

F
-1730.1/100

We analyze CKMTF's fundamental strength across five key dimensions:

Efficiency Score

Weak

CKMTF struggles to generate sufficient returns from assets.

ROA > 10%
-1.02%

Valuation Score

Excellent

CKMTF trades at attractive valuation levels.

PE < 25
-4.96
PEG Ratio < 2
-0.06

Growth Score

Weak

CKMTF faces weak or negative growth trends.

Revenue Growth > 5%
N/A
EPS Growth > 10%
N/A

Financial Health Score

Excellent

CKMTF maintains a strong and stable balance sheet.

Debt/Equity < 1
-1.32
Current Ratio > 1
2.07

Profitability Score

Weak

CKMTF struggles to sustain strong margins.

ROE > 15%
257.94%
Net Margin ≥ 15%
-19.25%
Positive Free Cash Flow
No

Key Financial Metrics

Is CKMTF Expensive or Cheap?

P/E Ratio

CKMTF trades at -4.96 times earnings. This suggests potential undervaluation.

-4.96

PEG Ratio

When adjusting for growth, CKMTF's PEG of -0.06 indicates potential undervaluation.

-0.06

Price to Book

The market values Carmat SA at -6.11 times its book value. This may indicate undervaluation.

-6.11

EV/EBITDA

Enterprise value stands at -0.49 times EBITDA. This is generally considered low.

-0.49

How Well Does CKMTF Make Money?

Net Profit Margin

For every $100 in sales, Carmat SA keeps $-19.25 as profit after all expenses.

-19.25%

Operating Margin

Core operations generate -18.75 in profit for every $100 in revenue, before interest and taxes.

-18.75%

ROE

Management delivers $2.58 in profit for every $100 of shareholder equity.

2.58%

ROA

Carmat SA generates $-1.02 in profit for every $100 in assets, demonstrating efficient asset deployment.

-1.02%

Following the Money - Real Cash Generation

Operating Cash Flow

Carmat SA generates limited operating cash flow of $-14.42M, signaling weaker underlying cash strength.

$-14.42M

Free Cash Flow

Carmat SA generates weak or negative free cash flow of $-15.77M, restricting financial flexibility.

$-15.77M

FCF Per Share

Each share generates $-2.36 in free cash annually.

$-2.36

FCF Yield

CKMTF converts -81.10% of its market value into free cash.

-81.10%

Financial Ratios Analysis

Valuation Ratios

P/E Ratio

Price to earnings ratio

-4.96

vs 25 benchmark

PEG Ratio

Price/earnings to growth ratio

-0.06

vs 25 benchmark

P/B Ratio

Price to book value ratio

-6.11

vs 25 benchmark

P/S Ratio

Price to sales ratio

25.76

vs 25 benchmark

Financial Health

Debt/Equity

Total debt to shareholders' equity

-1.32

vs 25 benchmark

Current Ratio

Current assets to current liabilities

2.07

vs 25 benchmark

Efficiency Ratios

ROE

Return on equity percentage

2.58

vs 25 benchmark

ROA

Return on assets percentage

-1.02

vs 25 benchmark

ROCE

Return on capital employed

-1.61

vs 25 benchmark

How CKMTF Stacks Against Its Sector Peers

MetricCKMTF ValueSector AveragePerformance
P/E Ratio-4.9629.45 Better (Cheaper)
ROE257.94%779.00% Weak
Net Margin-1925.00%-24930.00% (disorted) Weak
Debt/Equity-1.320.26 Strong (Low Leverage)
Current Ratio2.074.65 Strong Liquidity
ROA-101.57%-19333.00% (disorted) Weak

CKMTF outperforms its industry in 3 out of 6 key metrics, but lagging in ROE.

Historical Growth Performance

5-Year Growth Trajectory

This section reviews Carmat SA's 5-year compound annual growth rate (CAGR) and compares its performance against the typical investment style of its industry.

Revenue CAGR

N/A

Industry Style: Defensive, Growth, Innovation

EPS CAGR

N/A

Industry Style: Defensive, Growth, Innovation

FCF CAGR

N/A

Industry Style: Defensive, Growth, Innovation

Fundamental Analysis FAQ